Oxurion's Exagis Platform Gains Major Market Validation with Pierre Fabre Laboratories

Oxurion NV, a biopharmaceutical company based in Leuven, Belgium, announced that Pierre Fabre Laboratories has adopted its Exagis clinical data management platform. Developed by Oxurion's subsidiary Axiodis CRO, Exagis represents a significant commercial success for the company.

The platform, originally created to meet stringent data management standards, has evolved into a comprehensive Clinical Data Management System (CDMS). Its modular and scalable nature allows it to adapt to various clinical study configurations and organizational needs, serving biotech companies and large pharmaceutical groups alike.

Aline Stennevin of Pierre Fabre Dermo-Cosmétique praised Exagis for its operational efficiency and regulatory compliance. This collaboration underscores Oxurion's strategy to position Exagis as a core software asset in the industry.